In every type of financing, from IPOs and follow-on public offerings to private placements and venture capital rounds, the med-tech industry produced more money and completed more financings in 2018 than the prior year, reflecting the same significant jump in activity seen with its biopharma counterpart. What is different, however, is that med tech experienced a 38.43 percent increase in amount raised year-over-year, whereas biopharma showed a 29.64 percent increase. Read More
